Advertisement
Screener

BIO-RAD LABORATORIES, INC. (BIO.B) APIC, Share-based Payment Arrangement, Increase for Cost Recognition

2.0 / 5 stars · 47/120 Roast Me

BIO-RAD LABORATORIES, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition

BIO-RAD LABORATORIES, INC. (BIO.B) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $14.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Shareholders' Equity

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-04

  • BIO-RAD LABORATORIES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $14.50M, a 21.85% increase year-over-year.
  • BIO-RAD LABORATORIES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $15.00M, a 1.96% decline year-over-year.
  • BIO-RAD LABORATORIES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $14.90M, a 5.10% decline year-over-year.
  • BIO-RAD LABORATORIES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $11.90M, a 20.67% decline year-over-year.
  • BIO-RAD LABORATORIES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $58.00M, a 6.90% decline from fiscal 2024.
  • BIO-RAD LABORATORIES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $62.30M, a 1.63% increase from fiscal 2023.
  • BIO-RAD LABORATORIES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $61.30M, a 0.66% increase from fiscal 2022.
  • BIO-RAD LABORATORIES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $60.90M, a 19.04% increase from fiscal 2021.
Period endAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filedAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed
2026-06-30$14.50M
10-Q · filed 2026-08-04
$29.50M
derived: sum of 2 quarters · filed 2026-08-04
2026-03-31$15.00M
10-Q · filed 2026-08-04
2025-12-31$58.00M
10-K · filed 2026-02-13
2025-09-30$14.90M
10-Q · filed 2025-10-29
$26.80M
derived: sum of 2 quarters · filed 2026-08-04
$42.10M
derived: sum of 3 quarters · filed 2026-08-04
2025-06-30$11.90M
10-Q · filed 2026-08-04
$27.20M
derived: sum of 2 quarters · filed 2026-08-04
2025-03-31$15.30M
10-Q · filed 2026-08-04
2024-12-31$62.30M
10-K · filed 2026-02-13
2024-09-30$15.70M
10-Q · filed 2025-10-29
$15.68M
10-Q · filed 2024-10-31
$30.70M
derived: sum of 2 quarters · filed 2025-10-29
$46.00M
derived: sum of 3 quarters · filed 2025-10-29
2024-06-30$15.00M
10-Q · filed 2025-10-29
$15.00M
10-Q · filed 2024-08-02
$30.30M
derived: sum of 2 quarters · filed 2025-10-29
2024-03-31$15.30M
10-Q · filed 2025-10-29
$15.26M
10-Q · filed 2024-05-08
2023-12-31$61.30M
10-K · filed 2026-02-13
$61.27M
10-K · filed 2024-02-16
2023-09-30$15.95M
10-Q · filed 2024-10-31
$28.51M
derived: sum of 2 quarters · filed 2024-10-31
$45.12M
derived: sum of 3 quarters · filed 2024-10-31
2023-06-30$12.56M
10-Q · filed 2024-10-31
$29.17M
derived: sum of 2 quarters · filed 2024-10-31
2023-03-31$16.61M
10-Q · filed 2024-10-31
2022-12-31$60.90M
10-K · filed 2025-02-14
$60.92M
10-K · filed 2023-02-17
2022-09-30$15.73M
10-Q · filed 2023-10-27
$29.31M
derived: sum of 2 quarters · filed 2023-10-27
$42.83M
derived: sum of 3 quarters · filed 2023-10-27
2022-06-30$13.57M
10-Q · filed 2023-10-27
$27.09M
derived: sum of 2 quarters · filed 2023-10-27
2022-03-31$13.52M
10-Q · filed 2023-10-27
2021-12-31$51.16M
10-K · filed 2024-02-16
2021-09-30$13.14M
10-Q · filed 2022-10-28
$24.57M
derived: sum of 2 quarters · filed 2022-10-28
$36.24M
derived: sum of 3 quarters · filed 2022-10-28
2021-06-30$11.43M
10-Q · filed 2022-10-28
$23.10M
derived: sum of 2 quarters · filed 2022-10-28
2021-03-31$11.67M
10-Q · filed 2022-10-28
2020-12-31$41.56M
10-K · filed 2023-02-17
2020-09-30$10.73M
10-Q · filed 2021-10-29
$19.61M
derived: sum of 2 quarters · filed 2021-10-29
$29.26M
derived: sum of 3 quarters · filed 2021-10-29
2020-06-30$8.88M
10-Q · filed 2021-10-29
$18.53M
derived: sum of 2 quarters · filed 2021-10-29
2020-03-31$9.65M
10-Q · filed 2021-10-29
2019-12-31$35.59M
10-K · filed 2022-02-11
2019-09-30$9.03M
10-Q · filed 2020-10-30
$16.85M
derived: sum of 2 quarters · filed 2020-10-30
$25.35M
derived: sum of 3 quarters · filed 2020-10-30
2019-06-30$7.82M
10-Q · filed 2020-10-30
$16.32M
derived: sum of 2 quarters · filed 2020-10-30
2019-03-31$8.51M
10-Q · filed 2020-10-30
2018-12-31$27.84M
10-K · filed 2021-02-16
2018-09-30$7.08M
10-Q · filed 2019-11-01
$13.28M
derived: sum of 2 quarters · filed 2019-11-01
$19.17M
derived: sum of 3 quarters · filed 2019-11-01
2018-06-30$6.21M
10-Q · filed 2019-11-01
$12.09M
derived: sum of 2 quarters · filed 2019-11-01
2018-03-31$5.88M
10-Q · filed 2019-11-01
2017-12-31$23.44M
10-K · filed 2020-03-02
2016-12-31$19.73M
10-K · filed 2019-04-01
2015-12-31$16.98M
10-K · filed 2016-02-29
2014-12-31$14.89M
10-K · filed 2016-02-29
2013-12-31$13.66M
10-K · filed 2016-02-29
2012-12-31$12.94M
10-K · filed 2015-03-02
2011-12-31$10.74M
10-K · filed 2014-03-18
2010-12-31$10.20M
10-K · filed 2013-03-18
2009-12-31$9.08M
10-K · filed 2012-02-29
2008-12-31$7.33M
10-K · filed 2011-02-28